ShangBay Capital focuses its investments on early-stage opportunities within the medical device, biopharma, and healthcare technology sectors, particularly those addressing significant unmet clinical needs. Their strategy involves actively partnering with founders, leveraging their extensive industry experience and network to help commercialize products, navigate regulatory approvals, and expand market reach.
Portfolio
4
Fund Size
$2B
Top Stage
Series B
Last 12 Mo
0
Stage Distribution
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Avation Medical | Series C | $22M | Feb 2024 |
| Laplace Interventional Inc. | Series B | $12.9M | Jul 2023 |
| Berkeley Lights, Inc. | Growth | $95M | Oct 2018 |
| Refuge Biotechnologies, Inc. | Series B | $25M | May 2018 |
Top Co-Investors
Sequoia China1 shared
Danhua Capital1 shared
3E Bioventures Capital1 shared
WuXi Healthcare Ventures1 shared
Sequoia Capital1 shared
Cota Capital1 shared
Atinum Investment1 shared
Engage Ventures1 shared
Asahi Kasei1 shared
Angelini Ventures1 shared
JobsOhio1 shared
Avestria1 shared
Last updated: 3 March 2026